Related Experiment Video
Updated: May 18, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Modifying risk factors to prevent and treat erectile dysfunction.
Sidney Glina1, Ira D Sharlip, Wayne J G Hellstrom
1Hospital Ipiranga, Sao Paulo, Brazil.
Lifestyle changes like exercise, weight loss, and smoking cessation may improve erectile dysfunction (ED), especially in men without comorbidities. Further research is needed to fully understand these effects.
Area of Science:
- Urology
- Men's Health
- Cardiovascular Health
Background:
- Erectile dysfunction (ED) is prevalent in men over 40, with increasing rates alongside age.
- Key risk factors include comorbidities like heart disease, diabetes, dyslipidemia, hypertension, and depression.
- Modifiable lifestyle factors such as physical activity, smoking, alcohol consumption, diabetes control, and obesity are also linked to ED.
Purpose of the Study:
- To explore the association between modifiable behavioral factors and ED.
- To identify potential intervention strategies for preventing and improving erectile function, particularly in men without diagnosed comorbidities.
Main Methods:
- Review of existing literature on lifestyle factors and erectile dysfunction.
- Analysis of evidence linking behavioral changes to erectile function.
- Examination of mechanisms through which lifestyle modifications may impact ED.
Main Results:
- Evidence linking lifestyle modifications to improved erectile function is not yet fully compelling.
- Weight loss may improve ED through reduced inflammation, increased testosterone, and enhanced mood.
- Recommendations include patient education on exercise, weight management (BMI < 30 kg/m²), and smoking cessation.
Conclusions:
- Lifestyle modifications show promise for improving erectile function, especially in men without comorbidities.
- For men with comorbidities, lifestyle changes are crucial for preventing or reducing sexual dysfunction.
- Management may involve precise glycemic control for diabetics and pharmacologic therapies with fewer sexual side effects for hypertension and depression.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Peripheral Artery Disease III: Interprofessional Care